This website is an independent initiative of the historic and founding shareholders of OSE Immunotherapeutics. It is not the company's corporate website. Its purpose is to inform other shareholders and stakeholders about our positions and proposals in the context of the debate on strategy and governance.

Latest news

Letter to shareholders ahead of OSE Immunotherapeutics SA’s June 25, 2025 Combined General Meeting, setting out the reasons for our 10 draft resolutions.

Letter to shareholders ahead of OSE Immunotherapeutics SA’s June 25, 2025 Combined General Meeting, setting out the reasons for our 10 draft resolutions.

Read all
2560 904 OSE Immuno Together
  • 1
  • 2